These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11134027)

  • 1. The valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance.
    Selmi B; Boretto J; Navarro JM; Sire J; Longhi S; Guerreiro C; Mulard L; Sarfati S; Canard B
    J Biol Chem; 2001 Apr; 276(17):13965-74. PubMed ID: 11134027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture.
    Lacey SF; Larder BA
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1428-32. PubMed ID: 7522429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.
    Matamoros T; Nevot M; Martínez MA; Menéndez-Arias L
    J Biol Chem; 2009 Nov; 284(47):32792-802. PubMed ID: 19801659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine.
    Lennerstrand J; Stammers DK; Larder BA
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2144-6. PubMed ID: 11408240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA primers.
    Matamoros T; Franco S; Vázquez-Alvarez BM; Mas A; Martínez MA; Menéndez-Arias L
    J Biol Chem; 2004 Jun; 279(23):24569-77. PubMed ID: 15047690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase by a stavudine analogue, 4'-ethynyl stavudine triphosphate.
    Yang G; Wang J; Cheng Y; Dutschman GE; Tanaka H; Baba M; Cheng YC
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2035-42. PubMed ID: 18391035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase.
    Boyer PL; Das K; Arnold E; Hughes SH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7184-96. PubMed ID: 26324274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of HIV-1 reverse transcriptase/d4TTP complex: Novel DNA cross-linking site and pH-dependent conformational changes.
    Martinez SE; Bauman JD; Das K; Arnold E
    Protein Sci; 2019 Mar; 28(3):587-597. PubMed ID: 30499174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates.
    Meyer PR; Matsuura SE; Schinazi RF; So AG; Scott WA
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3465-72. PubMed ID: 11083661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.
    Crespan E; Locatelli GA; Cancio R; Hübscher U; Spadari S; Maga G
    Antimicrob Agents Chemother; 2005 Jan; 49(1):342-9. PubMed ID: 15616314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis.
    Ray AS; Murakami E; Basavapathruni A; Vaccaro JA; Ulrich D; Chu CK; Schinazi RF; Anderson KS
    Biochemistry; 2003 Jul; 42(29):8831-41. PubMed ID: 12873144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished HIV-1 sensitivity to stavudine in patients on prolonged therapy occurs only at low levels and cannot be attributed to any single amino acid substitution in reverse transcriptase.
    Salomon H; Montaner JS; Belmonte A; Wainberg MA
    Antivir Ther; 1998; 3(3):177-82. PubMed ID: 10682135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine.
    Cases-González CE; Franco S; Martínez MA; Menéndez-Arias L
    J Mol Biol; 2007 Jan; 365(2):298-309. PubMed ID: 17070543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
    Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
    AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for activation of alpha-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase.
    Meyer P; Schneider B; Sarfati S; Deville-Bonne D; Guerreiro C; Boretto J; Janin J; Véron M; Canard B
    EMBO J; 2000 Jul; 19(14):3520-9. PubMed ID: 10899107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.
    Paolucci S; Baldanti F; Campanini G; Cancio R; Belfiore A; Maga G; Gerna G
    Antiviral Res; 2007 Nov; 76(2):99-103. PubMed ID: 17640745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights into the role of Val75 of HIV-1 reverse transcriptase in misinsertion and mispair extension fidelity of DNA synthesis.
    Matamoros T; Kim B; Menéndez-Arias L
    J Mol Biol; 2008 Feb; 375(5):1234-48. PubMed ID: 18155043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pyrophosphatase activity associated with purified HIV-1 particles.
    Ducloux C; Mougel M; Goldschmidt V; Didierlaurent L; Marquet R; Isel C
    Biochimie; 2012 Dec; 94(12):2498-507. PubMed ID: 22766015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates.
    Duan C; Poticha D; Stoeckli TC; Petropoulos CJ; Whitcomb JM; McHenry CS; Kuritzkes DR
    J Infect Dis; 2001 Nov; 184(10):1336-40. PubMed ID: 11679926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.